RT Journal Article
SR Electronic
T1 RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001499
DO 10.1136/jitc-2020-001499
VO 8
IS 2
A1 Cohen, Romain
A1 Bennouna, Jaafar
A1 Meurisse, Aurélia
A1 Tournigand, Christophe
A1 De La Fouchardière, Christelle
A1 Tougeron, David
A1 Borg, Christophe
A1 Mazard, Thibault
A1 Chibaudel, Benoist
A1 Garcia-Larnicol, Marie-Line
A1 Svrcek, Magali
A1 Vernerey, Dewi
A1 Menu, Yves
A1 André, Thierry
YR 2020
UL http://jitc.bmj.com/content/8/2/e001499.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.